01 |
International Genomics Consortium |
Ovarian serous cystadenocarcinoma |
IGC |
02 |
MD Anderson Cancer Center |
Glioblastoma multiforme |
IGC |
04 |
Gynecologic Oncology Group |
Ovarian serous cystadenocarcinoma |
IGC |
05 |
Indivumed |
Lung adenocarcinoma |
IGC |
06 |
Henry Ford Hospital |
Glioblastoma multiforme |
IGC |
07 |
TGen |
Cell Line Control |
IGC |
08 |
UCSF |
Glioblastoma multiforme |
IGC |
09 |
UCSF |
Ovarian serous cystadenocarcinoma |
IGC |
10 |
MD Anderson Cancer Center |
Ovarian serous cystadenocarcinoma |
IGC |
11 |
MD Anderson Cancer Center |
Lung squamous cell carcinoma |
IGC |
12 |
Duke |
Glioblastoma multiforme |
IGC |
13 |
Memorial Sloan Kettering |
Ovarian serous cystadenocarcinoma |
IGC |
14 |
Emory University |
Glioblastoma multiforme |
IGC |
15 |
Mayo Clinic - Rochester |
Glioblastoma multiforme |
IGC |
16 |
Toronto Western Hospital |
Glioblastoma multiforme |
IGC |
17 |
Washington University |
Lung adenocarcinoma |
IGC |
18 |
Princess Margaret Hospital (Canada) |
Lung squamous cell carcinoma |
IGC |
19 |
Case Western |
Glioblastoma multiforme |
IGC |
1Z |
Johns Hopkins |
Thymoma |
NCH |
20 |
Fox Chase Cancer Center |
Ovarian serous cystadenocarcinoma |
IGC |
21 |
Fox Chase Cancer Center |
Lung squamous cell carcinoma |
IGC |
22 |
Mayo Clinic - Rochester |
Lung squamous cell carcinoma |
IGC |
23 |
Cedars Sinai |
Ovarian serous cystadenocarcinoma |
IGC |
24 |
Washington University |
Ovarian serous cystadenocarcinoma |
IGC |
25 |
Mayo Clinic - Rochester |
Ovarian serous cystadenocarcinoma |
IGC |
26 |
University of Florida |
Glioblastoma multiforme |
IGC |
27 |
Milan - Italy, Fondazione IRCCS Instituto Neuroligico C. Besta |
Glioblastoma multiforme |
IGC |
28 |
Cedars Sinai |
Glioblastoma multiforme |
IGC |
29 |
Duke |
Ovarian serous cystadenocarcinoma |
IGC |
2A |
Memorial Sloan Kettering Cancer Center |
Prostate adenocarcinoma |
NCH |
2E |
University of Kansas Medical Center |
Uterine Corpus Endometrial Carcinoma |
NCH |
2F |
Erasmus MC |
Bladder Urothelial Carcinoma |
NCH |
2G |
Erasmus MC |
Testicular Germ Cell Tumors |
NCH |
2H |
Erasmus MC |
Esophageal carcinoma |
NCH |
2J |
Mayo Clinic |
Pancreatic adenocarcinoma |
NCH |
2K |
Greenville Health System |
Kidney renal papillary cell carcinoma |
NCH |
2L |
Technical University of Munich |
Pancreatic adenocarcinoma |
NCH |
2M |
Technical University of Munich |
Esophageal carcinoma |
NCH |
2N |
Technical University of Munich |
Stomach adenocarcinoma |
NCH |
2P |
University of California San Diego |
Pancreatic adenocarcinoma |
NCH |
2V |
University of California San Diego |
Liver hepatocellular carcinoma |
NCH |
2W |
University of New Mexico |
Cervical squamous cell carcinoma and endocervical adenocarcinoma |
NCH |
2X |
ABS IUPUI |
Testicular Germ Cell Tumors |
NCH |
2Y |
Moffitt Cancer Center |
Liver hepatocellular carcinoma |
NCH |
2Z |
Moffitt Cancer Center |
Kidney renal papillary cell carcinoma |
NCH |
30 |
Harvard |
Ovarian serous cystadenocarcinoma |
IGC |
31 |
Imperial College |
Ovarian serous cystadenocarcinoma |
IGC |
32 |
St. Joseph's Hospital (AZ) |
Glioblastoma multiforme |
IGC |
33 |
Johns Hopkins |
Lung squamous cell carcinoma |
IGC |
34 |
University of Pittsburgh |
Lung squamous cell carcinoma |
IGC |
35 |
Cureline |
Lung adenocarcinoma |
IGC |
36 |
BC Cancer Agency |
Ovarian serous cystadenocarcinoma |
IGC |
37 |
Cureline |
Lung squamous cell carcinoma |
IGC |
38 |
UNC |
Lung adenocarcinoma |
IGC |
39 |
MSKCC |
Lung squamous cell carcinoma |
IGC |
3A |
Moffitt Cancer Center |
Pancreatic adenocarcinoma |
NCH |
3B |
Moffitt Cancer Center |
Sarcoma |
NCH |
3C |
Columbia University |
Breast invasive carcinoma |
NCH |
3E |
Columbia University |
Pancreatic adenocarcinoma |
NCH |
3G |
MD Anderson Cancer Center |
Thymoma |
NCH |
3H |
MD Anderson Cancer Center |
Mesothelioma |
NCH |
3J |
Carle Cancer Center |
Breast invasive carcinoma |
NCH |
3K |
Boston Medical Center |
Liver hepatocellular carcinoma |
NCH |
3L |
Albert Einstein Medical Center |
Colon adenocarcinoma |
NCH |
3M |
University of Kansas Medical Center |
Stomach adenocarcinoma |
NCH |
3N |
Greenville Health System |
Skin Cutaneous Melanoma |
NCH |
3P |
Greenville Health System |
Ovarian serous cystadenocarcinoma |
NCH |
3Q |
Greenville Health Systems |
Thymoma |
NCH |
3R |
University of New Mexico |
Sarcoma |
NCH |
3S |
University of New Mexico |
Thymoma |
NCH |
3T |
Emory University |
Thymoma |
NCH |
3U |
University of Chicago |
Mesothelioma |
NCH |
3W |
University of California San Diego |
Sarcoma |
NCH |
3X |
Alberta Health Services |
Cholangiocarcinoma |
NCH |
3Z |
Mary Bird Perkins Cancer Center - Our Lady of the Lake |
Kidney renal clear cell carcinoma |
NCH |
41 |
Christiana Healthcare |
Glioblastoma multiforme |
IGC |
42 |
Christiana Healthcare |
Ovarian serous cystadenocarcinoma |
IGC |
43 |
Christiana Healthcare |
Lung squamous cell carcinoma |
IGC |
44 |
Christiana Healthcare |
Lung adenocarcinoma |
IGC |
46 |
St. Joseph's Medical Center (MD) |
Lung squamous cell carcinoma |
IGC |
49 |
Johns Hopkins |
Lung adenocarcinoma |
IGC |
4A |
Mary Bird Perkins Cancer Center - Our Lady of the Lake |
Kidney renal papillary cell carcinoma |
NCH |
4B |
Mary Bird Perkins Cancer Center - Our Lady of the Lake |
Lung adenocarcinoma |
NCH |
4C |
Mary Bird Perkins Cancer Center - Our Lady of the Lake |
Thyroid carcinoma |
NCH |
4D |
Molecular Response |
Ovarian serous cystadenocarcinoma |
NCH |
4E |
Molecular Response |
Uterine Corpus Endometrial Carcinoma |
NCH |
4G |
Sapienza University of Rome |
Cholangiocarcinoma |
NCH |
4H |
Proteogenex, Inc. |
Breast invasive carcinoma |
NCH |
4J |
Proteogenex, Inc. |
Cervical squamous cell carcinoma and endocervical adenocarcinoma |
NCH |
4K |
Proteogenex, Inc. |
Testicular Germ Cell Tumors |
NCH |
4L |
Proteogenex, Inc. |
Prostate adenocarcinoma |
NCH |
4N |
Mary Bird Perkins Cancer Center - Our Lady of the Lake |
Colon adenocarcinoma |
NCH |
4P |
Duke University |
Head and Neck squamous cell carcinoma |
NCH |
4Q |
Duke University |
Sarcoma |
NCH |
4R |
Duke University |
Liver hepatocellular carcinoma |
NCH |
4S |
Duke University |
Prostate adenocarcinoma |
NCH |
4T |
Duke University |
Colon adenocarcinoma |
NCH |
4V |
Hospital Louis Pradel |
Thymoma |
NCH |
4W |
University of Miami |
Glioblastoma multiforme |
NCH |
4X |
Yale University |
Thymoma |
NCH |
4Y |
Medical College of Wisconsin |
Sarcoma |
NCH |
4Z |
Barretos Cancer Hospital |
Bladder Urothelial Carcinoma |
NCH |
50 |
University of Pittsburgh |
Lung adenocarcinoma |
IGC |
51 |
UNC |
Lung squamous cell carcinoma |
IGC |
52 |
University of Miami |
Lung squamous cell carcinoma |
IGC |
53 |
University of Miami |
Lung adenocarcinoma |
IGC |
55 |
International Genomics Consortium |
Lung adenocarcinoma |
IGC |
56 |
International Genomics Consortium |
Lung squamous cell carcinoma |
IGC |
57 |
International Genomics Consortium |
Ovarian serous cystadenocarcinoma |
IGC |
58 |
Thoraxklinik at University Hospital Heidelberg |
Lung squamous cell carcinoma |
IGC |
59 |
Roswell Park |
Ovarian serous cystadenocarcinoma |
IGC |
5A |
Wake Forest University |
Cholangiocarcinoma |
NCH |
5B |
Medical College of Wisconsin |
Uterine Corpus Endometrial Carcinoma |
NCH |
5C |
Cureline |
Liver hepatocellular carcinoma |
NCH |
5D |
University of Miami |
Sarcoma |
NCH |
5F |
Duke University |
Thyroid carcinoma |
NCH |
5G |
Cleveland Clinic Foundation |
Thymoma |
NCH |
5H |
Retina Consultants Houston |
Uveal Melanoma |
NCH |
5J |
Cureline |
Acute Myeloid Leukemia |
NCH |
5K |
St. Joseph's Hospital AZ |
Thymoma |
NCH |
5L |
University of Sao Paulo |
Breast invasive carcinoma |
NCH |
5M |
University of Sao Paulo |
Colon adenocarcinoma |
NCH |
5N |
University Hospital Erlangen |
Bladder Urothelial Carcinoma |
NCH |
5P |
University Hospital Erlangen |
Kidney renal papillary cell carcinoma |
NCH |
5Q |
Proteogenex, Inc |
Pancreatic adenocarcinoma |
NCH |
5R |
Proteogenex, Inc |
Liver hepatocellular carcinoma |
NCH |
5S |
Holy Cross |
Uterine Corpus Endometrial Carcinoma |
NCH |
5T |
Holy Cross |
Breast invasive carcinoma |
NCH |
5U |
Regina Elena National Cancer Institute |
Thymoma |
NCH |
5V |
Roswell Park |
Thymoma |
NCH |
5W |
University of Alabama |
Uterine Corpus Endometrial Carcinoma |
NCH |
5X |
University of Alabama |
Ovarian serous cystadenocarcinoma |
NCH |
60 |
Roswell Park |
Lung squamous cell carcinoma |
IGC |
61 |
University of Pittsburgh |
Ovarian serous cystadenocarcinoma |
IGC |
62 |
Thoraxklinik at University Hospital Heidelberg |
Lung adenocarcinoma |
IGC |
63 |
Ontario Institute for Cancer Research |
Lung squamous cell carcinoma |
IGC |
64 |
Fox Chase |
Lung adenocarcinoma |
IGC |
65 |
Roswell Park |
Glioblastoma multiforme |
IGC |
66 |
Indivumed |
Lung squamous cell carcinoma |
IGC |
67 |
St Joseph's Medical Center (MD) |
Lung adenocarcinoma |
IGC |
68 |
Washington University - Cleveland Clinic |
Lung squamous cell carcinoma |
IGC |
69 |
Washington University - Cleveland Clinic |
Lung adenocarcinoma |
IGC |
6A |
University of Kansas |
Lung squamous cell carcinoma |
NCH |
6D |
University of Oklahoma HSC |
Kidney renal clear cell carcinoma |
NCH |
6G |
University of Sao Paulo |
Rectum adenocarcinoma |
NCH |
6H |
Test For lcml |
Chronic Myelogenous Leukemia |
NCH |
70 |
ILSBio |
Lung squamous cell carcinoma |
IGC |
71 |
ILSBio |
Lung adenocarcinoma |
IGC |
72 |
NCH |
Ovarian serous cystadenocarcinoma |
IGC |
73 |
Roswell Park |
Lung adenocarcinoma |
IGC |
74 |
Swedish Neurosciences |
Glioblastoma multiforme |
IGC |
75 |
Ontario Institute for Cancer Research (OICR) |
Lung adenocarcinoma |
IGC |
76 |
Thomas Jefferson University |
Glioblastoma multiforme |
IGC |
77 |
Prince Charles Hospital |
Lung squamous cell carcinoma |
IGC |
78 |
Prince Charles Hospital |
Lung adenocarcinoma |
IGC |
79 |
Ontario Institute for Cancer Research (OICR)/Ottawa |
Lung squamous cell carcinoma |
IGC |
80 |
Ontario Institute for Cancer Research (OICR)/Ottawa |
Lung adenocarcinoma |
IGC |
81 |
CHI-Penrose Colorado |
Glioblastoma multiforme |
IGC |
82 |
CHI-Penrose Colorado |
Lung squamous cell carcinoma |
IGC |
83 |
CHI-Penrose Colorado |
Lung adenocarcinoma |
IGC |
85 |
Asterand |
Lung squamous cell carcinoma |
IGC |
86 |
Asterand |
Lung adenocarcinoma |
IGC |
87 |
International Genomics Consortium |
Glioblastoma multiforme |
IGC |
90 |
ABS - IUPUI |
Lung squamous cell carcinoma |
IGC |
91 |
ABS - IUPUI |
Lung adenocarcinoma |
IGC |
92 |
Washington University - St. Louis |
Lung squamous cell carcinoma |
IGC |
93 |
Washington University - St. Louis |
Lung adenocarcinoma |
IGC |
94 |
Washington University - Emory |
Lung squamous cell carcinoma |
IGC |
95 |
Washington University - Emory |
Lung adenocarcinoma |
IGC |
96 |
Washington University - NYU |
Lung squamous cell carcinoma |
IGC |
97 |
Washington University - NYU |
Lung adenocarcinoma |
IGC |
98 |
Washington University - Alabama |
Lung squamous cell carcinoma |
IGC |
99 |
Washington University - Alabama |
Lung adenocarcinoma |
IGC |
A1 |
UCSF |
Breast invasive carcinoma |
NCH |
A2 |
Walter Reed |
Breast invasive carcinoma |
NCH |
A3 |
International Genomics Consortium |
Kidney renal clear cell carcinoma |
IGC |
A4 |
International Genomics Consortium |
Kidney renal papillary cell carcinoma |
IGC |
A5 |
Cedars Sinai |
Uterine Corpus Endometrial Carcinoma |
NCH |
A6 |
Christiana Healthcare |
Colon adenocarcinoma |
IGC |
A7 |
Christiana Healthcare |
Breast invasive carcinoma |
NCH |
A8 |
Indivumed |
Breast invasive carcinoma |
NCH |
AA |
Indivumed |
Colon adenocarcinoma |
IGC |
AB |
Washington University |
Acute Myeloid Leukemia |
NCH |
AC |
International Genomics Consortium |
Breast invasive carcinoma |
NCH |
AD |
International Genomics Consortium |
Colon adenocarcinoma |
IGC |
AF |
Christiana Healthcare |
Rectum adenocarcinoma |
IGC |
AG |
Indivumed |
Rectum adenocarcinoma |
IGC |
AH |
International Genomics Consortium |
Rectum adenocarcinoma |
IGC |
AJ |
International Genomics Conosrtium |
Uterine Corpus Endometrial Carcinoma |
NCH |
AK |
Fox Chase |
Kidney renal clear cell carcinoma |
IGC |
AL |
Fox Chase |
Kidney renal papillary cell carcinoma |
IGC |
AM |
Cureline |
Colon adenocarcinoma |
IGC |
AN |
Cureline |
Breast invasive carcinoma |
NCH |
AO |
MSKCC |
Breast invasive carcinoma |
NCH |
AP |
MSKCC |
Uterine Corpus Endometrial Carcinoma |
NCH |
AQ |
UNC |
Breast invasive carcinoma |
NCH |
AR |
Mayo |
Breast invasive carcinoma |
NCH |
AS |
St. Joseph's Medical Center-(MD) |
Kidney renal clear cell carcinoma |
IGC |
AT |
St. Joseph's Medical Center-(MD) |
Kidney renal papillary cell carcinoma |
IGC |
AU |
St. Joseph's Medical Center-(MD) |
Colon adenocarcinoma |
IGC |
AV |
NCH |
Cell Line Control |
NCH |
AW |
Cureline |
Uterine Corpus Endometrial Carcinoma |
NCH |
AX |
Gynecologic Oncology Group |
Uterine Corpus Endometrial Carcinoma |
NCH |
AY |
UNC |
Colon adenocarcinoma |
IGC |
AZ |
University of Pittsburgh |
Colon adenocarcinoma |
IGC |
B0 |
University of Pittsburgh |
Kidney renal clear cell carcinoma |
IGC |
B1 |
University of Pittsburgh |
Kidney renal papillary cell carcinoma |
IGC |
B2 |
Christiana Healthcare |
Kidney renal clear cell carcinoma |
IGC |
B3 |
Christiana Healthcare |
Kidney renal papillary cell carcinoma |
IGC |
B4 |
Cureline |
Kidney renal clear cell carcinoma |
IGC |
B5 |
Duke |
Uterine Corpus Endometrial Carcinoma |
NCH |
B6 |
Duke |
Breast invasive carcinoma |
NCH |
B7 |
Cureline |
Stomach adenocarcinoma |
IGC |
B8 |
UNC |
Kidney renal clear cell carcinoma |
IGC |
B9 |
UNC |
Kidney renal papillary cell carcinoma |
IGC |
BA |
UNC |
Head and Neck squamous cell carcinoma |
IGC |
BB |
Johns Hopkins |
Head and Neck squamous cell carcinoma |
IGC |
BC |
UNC |
Liver hepatocellular carcinoma |
NCH |
BD |
University of Pittsburgh |
Liver hepatocellular carcinoma |
NCH |
BF |
Cureline |
Skin Cutaneous Melanoma |
NCH |
BG |
University of Pittsburgh |
Uterine Corpus Endometrial Carcinoma |
NCH |
BH |
University of Pittsburgh |
Breast invasive carcinoma |
NCH |
BI |
University of Pittsburgh |
Cervical squamous cell carcinoma and endocervical adenocarcinoma |
NCH |
BJ |
University of Pittsburgh |
Thyroid carcinoma |
IGC |
BK |
Christiana Healthcare |
Uterine Corpus Endometrial Carcinoma |
NCH |
BL |
Christiana Healthcare |
Bladder Urothelial Carcinoma |
NCH |
BM |
UNC |
Rectum adenocarcinoma |
IGC |
BP |
MSKCC |
Kidney renal clear cell carcinoma |
IGC |
BQ |
MSKCC |
Kidney renal papillary cell carcinoma |
IGC |
BR |
Asterand |
Stomach adenocarcinoma |
IGC |
BS |
University of Hawaii |
Uterine Corpus Endometrial Carcinoma |
NCH |
BT |
University of Pittsburgh |
Bladder Urothelial Carcinoma |
NCH |
BW |
St. Joseph's Medical Center-(MD) |
Liver hepatocellular carcinoma |
NCH |
C4 |
Indivumed |
Bladder Urothelial Carcinoma |
NCH |
C5 |
Medical College of Wisconsin |
Cervical squamous cell carcinoma and endocervical adenocarcinoma |
NCH |
C8 |
ILSBio |
Breast invasive carcinoma |
NCH |
C9 |
ILSBio |
Head and Neck squamous cell carcinoma |
NCH |
CA |
ILSBio |
Colon adenocarcinoma |
IGC |
CB |
ILSBio |
Kidney renal clear cell carcinoma |
IGC |
CC |
ILSBio |
Liver hepatocellular carcinoma |
NCH |
CD |
ILSBio |
Stomach adenocarcinoma |
IGC |
CE |
ILSBio |
Thyroid carcinoma |
IGC |
CF |
ILSBio |
Bladder Urothelial Carcinoma |
NCH |
CG |
Indivumed |
Stomach adenocarcinoma |
IGC |
CH |
Indivumed |
Prostate adenocarcinoma |
IGC |
CI |
University of Pittsburgh |
Rectum adenocarcinoma |
IGC |
CJ |
MD Anderson Cancer Center |
Kidney renal clear cell carcinoma |
IGC |
CK |
Harvard |
Colon adenocarcinoma |
IGC |
CL |
Harvard |
Rectum adenocarcinoma |
IGC |
CM |
MSKCC |
Colon adenocarcinoma |
IGC |
CN |
University of Pittsburgh |
Head and Neck squamous cell carcinoma |
IGC |
CQ |
University Health Network, Toronto |
Head and Neck squamous cell carcinoma |
IGC |
CR |
Vanderbilt University |
Head and Neck squamous cell carcinoma |
IGC |
CS |
Thomas Jefferson University |
Brain Lower Grade Glioma |
IGC |
CU |
UNC |
Bladder Urothelial Carcinoma |
NCH |
CV |
MD Anderson Cancer Center |
Head and Neck squamous cell carcinoma |
IGC |
CW |
Mayo Clinic - Rochester |
Kidney renal clear cell carcinoma |
IGC |
CX |
Medical College of Georgia |
Head and Neck squamous cell carcinoma |
IGC |
CZ |
Harvard |
Kidney renal clear cell carcinoma |
IGC |
D1 |
Mayo Clinic |
Uterine Corpus Endometrial Carcinoma |
NCH |
D3 |
MD Anderson |
Skin Cutaneous Melanoma |
NCH |
D5 |
Greater Poland Cancer Center |
Colon adenocarcinoma |
IGC |
D6 |
Greater Poland Cancer Center |
Head and Neck squamous cell carcinoma |
IGC |
D7 |
Greater Poland Cancer Center |
Stomach adenocarcinoma |
IGC |
D8 |
Greater Poland Cancer Center |
Breast invasive carcinoma |
NCH |
D9 |
Greater Poland Cancer Center |
Skin Cutaneous Melanoma |
NCH |
DA |
Yale |
Skin Cutaneous Melanoma |
NCH |
DB |
Mayo Clinic - Rochester |
Brain Lower Grade Glioma |
IGC |
DC |
MSKCC |
Rectum adenocarcinoma |
IGC |
DD |
Mayo Clinic - Rochester |
Liver hepatocellular carcinoma |
NCH |
DE |
University of North Carolina |
Thyroid carcinoma |
NCH |
DF |
Ontario Institute for Cancer Research |
Uterine Corpus Endometrial Carcinoma |
NCH |
DG |
Ontario Institute for Cancer Research |
Cervical squamous cell carcinoma and endocervical adenocarcinoma |
NCH |
DH |
University of Florida |
Brain Lower Grade Glioma |
IGC |
DI |
MD Anderson |
Uterine Corpus Endometrial Carcinoma |
NCH |
DJ |
Memorial Sloan Kettering |
Thyroid carcinoma |
NCH |
DK |
Memorial Sloan Kettering |
Bladder Urothelial Carcinoma |
NCH |
DM |
University Of Michigan |
Colon adenocarcinoma |
NCH |
DO |
Medical College of Georgia |
Thyroid carcinoma |
NCH |
DQ |
University Of Michigan |
Head and Neck squamous cell carcinoma |
IGC |
DR |
University of Hawaii |
Cervical squamous cell carcinoma and endocervical adenocarcinoma |
NCH |
DS |
Cedars Sinai |
Cervical squamous cell carcinoma and endocervical adenocarcinoma |
NCH |
DT |
ILSBio |
Rectum adenocarcinoma |
IGC |
DU |
Henry Ford Hospital |
Brain Lower Grade Glioma |
IGC |
DV |
NCI Urologic Oncology Branch |
Kidney renal clear cell carcinoma |
IGC |
DW |
NCI Urologic Oncology Branch |
Kidney renal papillary cell carcinoma |
IGC |
DX |
Memorial Sloan Kettering |
Sarcoma |
NCH |
DY |
University Of Michigan |
Rectum adenocarcinoma |
NCH |
DZ |
Mayo Clinic - Rochester |
Kidney renal papillary cell carcinoma |
IGC |
E1 |
Duke |
Brain Lower Grade Glioma |
IGC |
E2 |
Roswell Park |
Breast invasive carcinoma |
NCH |
E3 |
Roswell Park |
Thyroid carcinoma |
NCH |
E5 |
Roswell Park |
Bladder Urothelial Carcinoma |
NCH |
E6 |
Roswell Park |
Uterine Corpus Endometrial Carcinoma |
NCH |
E7 |
Asterand |
Bladder Urothelial Carcinoma |
NCH |
E8 |
Asterand |
Thyroid carcinoma |
NCH |
E9 |
Asterand |
Breast invasive carcinoma |
NCH |
EA |
Asterand |
Cervical squamous cell carcinoma and endocervical adenocarcinoma |
NCH |
EB |
Asterand |
Skin Cutaneous Melanoma |
NCH |
EC |
Asterand |
Uterine Corpus Endometrial Carcinoma |
NCH |
ED |
Asterand |
Liver hepatocellular carcinoma |
NCH |
EE |
University of Sydney |
Skin Cutaneous Melanoma |
NCH |
EF |
Cureline |
Rectum adenocarcinoma |
IGC |
EI |
Greater Poland Cancer Center |
Rectum adenocarcinoma |
IGC |
EJ |
University of Pittsburgh |
Prostate adenocarcinoma |
IGC |
EK |
Gynecologic Oncology Group |
Cervical squamous cell carcinoma and endocervical adenocarcinoma |
NCH |
EL |
MD Anderson |
Thyroid carcinoma |
NCH |
EM |
University Health Network |
Thyroid carcinoma |
NCH |
EO |
University Health Network |
Uterine Corpus Endometrial Carcinoma |
NCH |
EP |
Christiana Healthcare |
Liver hepatocellular carcinoma |
NCH |
EQ |
Christiana Healthcare |
Stomach adenocarcinoma |
IGC |
ER |
University of Pittsburgh |
Skin Cutaneous Melanoma |
NCH |
ES |
University of Florida |
Liver hepatocellular carcinoma |
NCH |
ET |
Johns Hopkins |
Thyroid carcinoma |
NCH |
EU |
CHI-Penrose Colorado |
Kidney renal clear cell carcinoma |
IGC |
EV |
CHI-Penrose Colorado |
Kidney renal papillary cell carcinoma |
IGC |
EW |
University of Miami |
Breast invasive carcinoma |
NCH |
EX |
University of North Carolina |
Cervical squamous cell carcinoma and endocervical adenocarcinoma |
NCH |
EY |
University of North Carolina |
Uterine Corpus Endometrial Carcinoma |
NCH |
EZ |
UNC |
Brain Lower Grade Glioma |
IGC |
F1 |
UNC |
Stomach adenocarcinoma |
IGC |
F2 |
UNC |
Pancreatic adenocarcinoma |
IGC |
F4 |
Asterand |
Colon adenocarcinoma |
IGC |
F5 |
Asterand |
Rectum adenocarcinoma |
IGC |
F6 |
Asterand |
Brain Lower Grade Glioma |
IGC |
F7 |
Asterand |
Head and Neck squamous cell carcinoma |
IGC |
F9 |
Asterand |
Kidney renal papillary cell carcinoma |
IGC |
FA |
Asterand |
Lymphoid Neoplasm Diffuse Large B-cell Lymphoma |
IGC |
FB |
Asterand |
Pancreatic adenocarcinoma |
IGC |
FC |
Asterand |
Prostate adenocarcinoma |
IGC |
FD |
BLN - University Of Chicago |
Bladder Urothelial Carcinoma |
NCH |
FE |
Ohio State University |
Thyroid carcinoma |
NCH |
FF |
SingHealth |
Lymphoid Neoplasm Diffuse Large B-cell Lymphoma |
IGC |
FG |
Case Western |
Brain Lower Grade Glioma |
IGC |
FH |
CHI-Penrose Colorado |
Thyroid carcinoma |
NCH |
FI |
Washington University |
Uterine Corpus Endometrial Carcinoma |
NCH |
FJ |
BLN - Baylor |
Bladder Urothelial Carcinoma |
NCH |
FK |
Johns Hopkins |
Thyroid carcinoma |
NCH |
FL |
University of Hawaii - Normal Study |
Uterine Corpus Endometrial Carcinoma |
NCH |
FM |
International Genomics Consortium |
Lymphoid Neoplasm Diffuse Large B-cell Lymphoma |
IGC |
FN |
International Genomics Consortium |
Brain Lower Grade Glioma |
IGC |
FP |
International Genomics Consortium |
Stomach adenocarcinoma |
IGC |
FQ |
Johns Hopkins |
Pancreatic adenocarcinoma |
IGC |
FR |
University of North Carolina |
Skin Cutaneous Melanoma |
NCH |
FS |
Essen |
Skin Cutaneous Melanoma |
NCH |
FT |
BLN - University of Miami |
Bladder Urothelial Carcinoma |
NCH |
FU |
International Genomics Consortium |
Cervical squamous cell carcinoma and endocervical adenocarcinoma |
NCH |
FV |
International Genomics Consortium |
Liver hepatocellular carcinoma |
NCH |
FW |
International Genomics Consortium |
Skin Cutaneous Melanoma |
NCH |
FX |
International Genomics Consortium |
Sarcoma |
NCH |
FY |
International Genomics Consortium |
Thyroid carcinoma |
NCH |
FZ |
University of Pittsburgh |
Pancreatic adenocarcinoma |
IGC |
G2 |
MD Anderson |
Bladder Urothelial Carcinoma |
NCH |
G3 |
Alberta Health Services |
Liver hepatocellular carcinoma |
NCH |
G4 |
Roswell Park |
Colon adenocarcinoma |
IGC |
G5 |
Roswell Park |
Rectum adenocarcinoma |
IGC |
G6 |
Roswell Park |
Kidney renal clear cell carcinoma |
IGC |
G7 |
Roswell Park |
Kidney renal papillary cell carcinoma |
IGC |
G8 |
Roswell Park |
Lymphoid Neoplasm Diffuse Large B-cell Lymphoma |
IGC |
G9 |
Roswell Park |
Prostate adenocarcinoma |
IGC |
GC |
International Genomics Consortium |
Bladder Urothelial Carcinoma |
NCH |
GD |
ABS - IUPUI |
Bladder Urothelial Carcinoma |
NCH |
GE |
ABS - IUPUI |
Thyroid carcinoma |
NCH |
GF |
ABS - IUPUI |
Skin Cutaneous Melanoma |
NCH |
GG |
ABS - IUPUI |
Uterine Corpus Endometrial Carcinoma |
NCH |
GH |
ABS - IUPUI |
Cervical squamous cell carcinoma and endocervical adenocarcinoma |
NCH |
GI |
ABS - IUPUI |
Breast invasive carcinoma |
NCH |
GJ |
ABS - IUPUI |
Liver hepatocellular carcinoma |
NCH |
GK |
ABS - IUPUI |
Kidney renal clear cell carcinoma |
IGC |
GL |
ABS - IUPUI |
Kidney renal papillary cell carcinoma |
IGC |
GM |
MD Anderson |
Breast invasive carcinoma |
NCH |
GN |
Roswell |
Skin Cutaneous Melanoma |
NCH |
GP |
MD Anderson |
Acute Myeloid Leukemia |
NCH |
GR |
University of Nebraska Medical Center (UNMC) |
Lymphoid Neoplasm Diffuse Large B-cell Lymphoma |
IGC |
GS |
Fundacio Clinic per a la Recerca Biomedica |
Lymphoid Neoplasm Diffuse Large B-cell Lymphoma |
IGC |
GU |
BLN - UT Southwestern Medical Center at Dallas |
Bladder Urothelial Carcinoma |
NCH |
GV |
BLN - Cleveland Clinic |
Bladder Urothelial Carcinoma |
NCH |
GZ |
BC Cancer Agency |
Lymphoid Neoplasm Diffuse Large B-cell Lymphoma |
IGC |
H1 |
Medical College of Georgia |
Stomach adenocarcinoma |
IGC |
H2 |
Christiana Healthcare |
Thyroid carcinoma |
NCH |
H3 |
ABS - IUPUI |
Lymphoid Neoplasm Diffuse Large B-cell Lymphoma |
IGC |
H4 |
Medical College of Georgia |
Bladder Urothelial Carcinoma |
NCH |
H5 |
Medical College of Georgia |
Uterine Corpus Endometrial Carcinoma |
NCH |
H6 |
Christiana Healthcare |
Pancreatic adenocarcinoma |
IGC |
H7 |
ABS - IUPUI |
Head and Neck squamous cell carcinoma |
IGC |
H8 |
ABS - IUPUI |
Pancreatic adenocarcinoma |
IGC |
H9 |
ABS - IUPUI |
Prostate adenocarcinoma |
IGC |
HA |
Alberta Health Services |
Stomach adenocarcinoma |
IGC |
HB |
University of North Carolina |
Sarcoma |
NCH |
HC |
International Genomics Consortium |
Prostate adenocarcinoma |
IGC |
HD |
International Genomics Consortium |
Head and Neck squamous cell carcinoma |
IGC |
HE |
Ontario Institute for Cancer Research (OICR) |
Kidney renal papillary cell carcinoma |
IGC |
HF |
Ontario Institute for Cancer Research (OICR) |
Stomach adenocarcinoma |
IGC |
HG |
Roswell Park |
Cervical squamous cell carcinoma and endocervical adenocarcinoma |
NCH |
HH |
Fox Chase |
Stomach adenocarcinoma |
IGC |
HI |
Fox Chase |
Prostate adenocarcinoma |
IGC |
HJ |
Fox Chase |
Stomach adenocarcinoma |
IGC |
HK |
Fox Chase |
Brain Lower Grade Glioma |
IGC |
HL |
Fox Chase |
Head and Neck squamous cell carcinoma |
IGC |
HM |
Christiana Healthcare |
Cervical squamous cell carcinoma and endocervical adenocarcinoma |
NCH |
HN |
Ontario Institute for Cancer Research (OICR) |
Breast invasive carcinoma |
NCH |
HP |
Ontario Institute for Cancer Research (OICR) |
Liver hepatocellular carcinoma |
NCH |
HQ |
Ontario Institute for Cancer Research (OICR) |
Bladder Urothelial Carcinoma |
NCH |
HR |
Ontario Institute for Cancer Research (OICR) |
Skin Cutaneous Melanoma |
NCH |
HS |
Ontario Institute for Cancer Research (OICR) |
Sarcoma |
NCH |
HT |
Case Western - St Joes |
Brain Lower Grade Glioma |
IGC |
HU |
National Cancer Center Korea |
Stomach adenocarcinoma |
IGC |
HV |
National Cancer Center Korea |
Pancreatic adenocarcinoma |
IGC |
HW |
MSKCC |
Brain Lower Grade Glioma |
IGC |
HZ |
International Genomics Consortium |
Pancreatic adenocarcinoma |
IGC |
IA |
Cleveland Clinic |
Kidney renal papillary cell carcinoma |
IGC |
IB |
Alberta Health Services |
Pancreatic adenocarcinoma |
IGC |
IC |
University of Pittsburgh |
Esophageal carcinoma |
NCH |
IE |
ABS - IUPUI |
Sarcoma |
NCH |
IF |
University of Texas MD Anderson Cancer Center |
Sarcoma |
NCH |
IG |
Asterand |
Esophageal carcinoma |
NCH |
IH |
University of Miami |
Skin Cutaneous Melanoma |
NCH |
IJ |
Christiana Healthcare |
Acute Myeloid Leukemia |
NCH |
IK |
Christiana Healthcare |
Brain Lower Grade Glioma |
IGC |
IM |
University of Miami |
Thyroid carcinoma |
NCH |
IN |
University of Pittsburgh |
Stomach adenocarcinoma |
IGC |
IP |
ABS - IUPUI |
Stomach adenocarcinoma |
IGC |
IQ |
University of Miami |
Head and Neck squamous cell carcinoma |
IGC |
IR |
Memorial Sloan Kettering |
Cervical squamous cell carcinoma and endocervical adenocarcinoma |
NCH |
IS |
Memorial Sloan Kettering |
Sarcoma |
NCH |
IW |
Cedars Sinai |
Sarcoma |
NCH |
IZ |
ABS - Lahey Clinic |
Kidney renal papillary cell carcinoma |
IGC |
J1 |
ABS - Lahey Clinic |
Lung squamous cell carcinoma |
IGC |
J2 |
ABS - Lahey Clinic |
Lung adenocarcinoma |
IGC |
J4 |
ABS - Lahey Clinic |
Prostate adenocarcinoma |
IGC |
J7 |
ILSBio |
Kidney renal papillary cell carcinoma |
IGC |
J8 |
Mayo Clinic |
Thyroid carcinoma |
NCH |
J9 |
Melbourne Health |
Prostate adenocarcinoma |
IGC |
JA |
ABS - Research Metrics Pakistan |
Head and Neck squamous cell carcinoma |
IGC |
JL |
ABS - Research Metrics Pakistan |
Breast invasive carcinoma |
NCH |
JU |
BLN - Baylor |
Uterine Corpus Endometrial Carcinoma |
NCH |
JV |
BLN - Baylor |
Sarcoma |
NCH |
JW |
BLN - Baylor |
Cervical squamous cell carcinoma and endocervical adenocarcinoma |
NCH |
JX |
Washington University |
Cervical squamous cell carcinoma and endocervical adenocarcinoma |
NCH |
JY |
University Health Network |
Esophageal carcinoma |
NCH |
JZ |
University of Rochester |
Esophageal carcinoma |
NCH |
K1 |
University of Pittsburgh |
Sarcoma |
NCH |
K4 |
ABS - Lahey Clinic |
Bladder Urothelial Carcinoma |
NCH |
K6 |
ABS - Lahey Clinic |
Uterine Corpus Endometrial Carcinoma |
NCH |
K7 |
ABS - Lahey Clinic |
Liver hepatocellular carcinoma |
NCH |
K8 |
ABS - Lahey Clinic |
Skin Cutaneous Melanoma |
NCH |
KA |
ABS - Lahey Clinic |
Esophageal carcinoma |
NCH |
KB |
University Health Network, Toronto |
Stomach adenocarcinoma |
IGC |
KC |
Cornell Medical College |
Prostate adenocarcinoma |
IGC |
KD |
Mount Sinai School of Medicine |
Sarcoma |
NCH |
KE |
Mount Sinai School of Medicine |
Uterine Corpus Endometrial Carcinoma |
NCH |
KF |
Christiana Healthcare |
Sarcoma |
NCH |
KG |
Baylor Network |
Pancreatic adenocarcinoma |
IGC |
KH |
Memorial Sloan Kettering |
Esophageal carcinoma |
NCH |
KJ |
University of Miami |
Uterine Corpus Endometrial Carcinoma |
NCH |
KK |
MD Anderson Cancer Center |
Prostate adenocarcinoma |
IGC |
KL |
MSKCC |
Kidney Chromophobe |
IGC |
KM |
NCI Urologic Oncology Branch |
Kidney Chromophobe |
IGC |
KN |
Harvard |
Kidney Chromophobe |
IGC |
KO |
MD Anderson Cancer Center |
Kidney Chromophobe |
IGC |
KP |
British Columbia Cancer Agency |
Uterine Corpus Endometrial Carcinoma |
NCH |
KQ |
Cornell Medical College |
Bladder Urothelial Carcinoma |
NCH |
KR |
University Of Michigan |
Liver hepatocellular carcinoma |
NCH |
KS |
University Of Michigan |
Thyroid carcinoma |
NCH |
KT |
Hartford |
Brain Lower Grade Glioma |
IGC |
KU |
Hartford |
Head and Neck squamous cell carcinoma |
IGC |
KV |
Hartford |
Kidney renal papillary cell carcinoma |
IGC |
KZ |
Hartford |
Stomach adenocarcinoma |
IGC |
L1 |
Hartford |
Pancreatic adenocarcinoma |
IGC |
L3 |
Gundersen Lutheran Health System |
Lung squamous cell carcinoma |
IGC |
L4 |
Gundersen Lutheran Health System |
Lung adenocarcinoma |
IGC |
L5 |
University of Michigan |
Esophageal carcinoma |
NCH |
L6 |
National Institutes of Health |
Thyroid carcinoma |
NCH |
L7 |
Christiana Care |
Esophageal carcinoma |
NCH |
L8 |
University of Miami |
Kidney renal papillary cell carcinoma |
NCH |
L9 |
Candler |
Lung adenocarcinoma |
IGC |
LA |
Candler |
Lung squamous cell carcinoma |
IGC |
LB |
Candler |
Pancreatic adenocarcinoma |
IGC |
LC |
Hartford Hospital |
Bladder Urothelial Carcinoma |
NCH |
LD |
Hartford Hospital |
Breast invasive carcinoma |
NCH |
LG |
Hartford Hospital |
Liver hepatocellular carcinoma |
NCH |
LH |
Hartford Hospital |
Skin Cutaneous Melanoma |
NCH |
LI |
Hartford Hospital |
Sarcoma |
NCH |
LK |
University of Pittsburgh |
Mesothelioma |
NCH |
LL |
Candler |
Breast invasive carcinoma |
NCH |
LN |
ILSBIO |
Esophageal carcinoma |
NCH |
LP |
ILSBIO |
Cervical squamous cell carcinoma and endocervical adenocarcinoma |
NCH |
LQ |
Gundersen Lutheran Health System |
Breast invasive carcinoma |
NCH |
LS |
Gundersen Lutheran Health System |
Cervical squamous cell carcinoma and endocervical adenocarcinoma |
NCH |
LT |
Gundersen Lutheran Health System |
Bladder Urothelial Carcinoma |
NCH |
M7 |
University of North Carolina |
Prostate adenocarcinoma |
NCH |
M8 |
Ontario Institute for Cancer Research (OICR) |
Pancreatic adenocarcinoma |
NCH |
M9 |
Ontario Institute for Cancer Research (OICR) |
Esophageal carcinoma |
NCH |
MA |
MD Anderson Cancer Center |
Cervical squamous cell carcinoma and endocervical adenocarcinoma |
NCH |
MB |
University of Minnesota |
Sarcoma |
NCH |
ME |
University of Minnesota |
Lung adenocarcinoma |
NCH |
MF |
University of Minnesota |
Lung squamous cell carcinoma |
NCH |
MG |
BLN - Baylor |
Prostate adenocarcinoma |
NCH |
MH |
BLN - Baylor |
Kidney renal papillary cell carcinoma |
NCH |
MI |
BLN - Baylor |
Liver hepatocellular carcinoma |
NCH |
MJ |
BLN - Baylor |
Sarcoma |
NCH |
MK |
BLN - Baylor |
Thyroid carcinoma |
NCH |
ML |
BLN - Baylor |
Lung squamous cell carcinoma |
NCH |
MM |
BLN - Baylor |
Kidney renal clear cell carcinoma |
NCH |
MN |
BLN - Baylor |
Lung adenocarcinoma |
NCH |
MO |
ILSBio |
Sarcoma |
NCH |
MP |
Washington University - Mayo Clinic |
Lung adenocarcinoma |
NCH |
MQ |
Washington University - NYU |
Mesothelioma |
NCH |
MR |
University of Minnesota |
Liver hepatocellular carcinoma |
NCH |
MS |
University of Minnesota |
Breast invasive carcinoma |
NCH |
MT |
University of Minnesota |
Head and Neck squamous cell carcinoma |
NCH |
MU |
University of Minnesota |
Cervical squamous cell carcinoma and endocervical adenocarcinoma |
NCH |
MV |
University of Minnesota |
Bladder Urothelial Carcinoma |
NCH |
MW |
University of Miami |
Kidney renal clear cell carcinoma |
NCH |
MX |
MSKCC |
Stomach adenocarcinoma |
NCH |
MY |
Montefiore Medical Center |
Cervical squamous cell carcinoma and endocervical adenocarcinoma |
NCH |
MZ |
Montefiore Medical Center |
Head and Neck squamous cell carcinoma |
NCH |
N1 |
Montefiore Medical Center |
Sarcoma |
NCH |
N5 |
MSKCC |
Uterine Carcinosarcoma |
NCH |
N6 |
University of Pittsburgh |
Uterine Carcinosarcoma |
NCH |
N7 |
Washington University |
Uterine Carcinosarcoma |
NCH |
N8 |
University of North Carolina |
Uterine Carcinosarcoma |
NCH |
N9 |
MD Anderson |
Uterine Carcinosarcoma |
NCH |
NA |
Duke University |
Uterine Carcinosarcoma |
NCH |
NB |
Washington University - CHUV |
Lung adenocarcinoma |
NCH |
NC |
Washington University - CHUV |
Lung squamous cell carcinoma |
NCH |
ND |
Cedars Sinai |
Uterine Carcinosarcoma |
NCH |
NF |
Mayo Clinic - Rochester |
Uterine Carcinosarcoma |
NCH |
NG |
Roswell Park |
Uterine Carcinosarcoma |
NCH |
NH |
Candler |
Colon adenocarcinoma |
NCH |
NI |
Roswell Park |
Liver hepatocellular carcinoma |
NCH |
NJ |
Washington University - Rush University |
Lung adenocarcinoma |
NCH |
NK |
Washington University - Rush University |
Lung squamous cell carcinoma |
NCH |
NM |
Cambridge BioSource |
Head and Neck squamous cell carcinoma |
NCH |
NP |
International Genomics Consortium |
Kidney Chromophobe |
NCH |
NQ |
International Genomics Consortium |
Mesothelioma |
NCH |
NS |
Gundersen Lutheran Health System |
Skin Cutaneous Melanoma |
NCH |
O1 |
Washington University - CALGB |
Lung adenocarcinoma |
NCH |
O2 |
Washington University - CALGB |
Lung squamous cell carcinoma |
NCH |
O8 |
Saint Mary's Health Care |
Liver hepatocellular carcinoma |
NCH |
O9 |
Saint Mary's Health Care |
Kidney renal papillary cell carcinoma |
NCH |
OC |
Saint Mary's Health Care |
Lung squamous cell carcinoma |
NCH |
OD |
Saint Mary's Health Care |
Skin Cutaneous Melanoma |
NCH |
OE |
Saint Mary's Health Care |
Pancreatic adenocarcinoma |
NCH |
OJ |
Saint Mary's Health Care |
Thyroid carcinoma |
NCH |
OK |
Mount Sinai School of Medicine |
Breast invasive carcinoma |
NCH |
OL |
University of Chicago |
Breast invasive carcinoma |
NCH |
OR |
University of Michigan |
Adrenocortical carcinoma |
NCH |
OU |
Roswell Park |
Adrenocortical carcinoma |
NCH |
OW |
International Genomics Consortium |
Miscellaneous |
NCH |
OX |
University of North Carolina |
Glioblastoma multiforme |
NCH |
OY |
University of North Carolina |
Ovarian serous cystadenocarcinoma |
NCH |
P3 |
Fred Hutchinson |
Head and Neck squamous cell carcinoma |
NCH |
P4 |
MD Anderson Cancer Center |
Kidney renal papillary cell carcinoma |
NCH |
P5 |
Cureline |
Brain Lower Grade Glioma |
NCH |
P6 |
Translational Genomics Research Institute |
Adrenocortical carcinoma |
NCH |
P7 |
Translational Genomics Research Institute |
Pheochromocytoma and Paraganglioma |
NCH |
P8 |
University of Pittsburgh |
Pheochromocytoma and Paraganglioma |
NCH |
P9 |
University of Minnesota |
Pancreatic adenocarcinoma |
NCH |
PA |
University of Minnesota |
Adrenocortical carcinoma |
NCH |
PB |
University of Minnesota |
Lymphoid Neoplasm Diffuse Large B-cell Lymphoma |
NCH |
PC |
Fox Chase |
Sarcoma |
NCH |
PD |
Fox Chase |
Liver hepatocellular carcinoma |
NCH |
PE |
Fox Chase |
Breast invasive carcinoma |
NCH |
PG |
Montefiore Medical Center |
Uterine Corpus Endometrial Carcinoma |
NCH |
PH |
Gundersen Lutheran |
Acute Myeloid Leukemia |
NCH |
PJ |
Gundersen Lutheran |
Kidney renal papillary cell carcinoma |
NCH |
PK |
University Health Network |
Adrenocortical carcinoma |
NCH |
PL |
Institute of Human Virology Nigeria |
Breast invasive carcinoma |
NCH |
PN |
Institute of Human Virology Nigeria |
Cervical squamous cell carcinoma and endocervical adenocarcinoma |
NCH |
PQ |
University of Colorado Denver |
Bladder Urothelial Carcinoma |
NCH |
PR |
Roswell Park |
Pheochromocytoma and Paraganglioma |
NCH |
PT |
Maine Medical Center |
Sarcoma |
NCH |
PZ |
ABS - Lahey Clinic |
Pancreatic adenocarcinoma |
NCH |
Q1 |
University of Oklahoma HSC |
Cervical squamous cell carcinoma and endocervical adenocarcinoma |
NCH |
Q2 |
University of Oklahoma HSC |
Kidney renal papillary cell carcinoma |
NCH |
Q3 |
University of Oklahoma HSC |
Pancreatic adenocarcinoma |
NCH |
Q4 |
Emory University |
Acute Myeloid Leukemia |
NCH |
Q9 |
Emory University |
Esophageal carcinoma |
NCH |
QA |
Emory University |
Liver hepatocellular carcinoma |
NCH |
QB |
Emory University |
Skin Cutaneous Melanoma |
NCH |
QC |
Emory University |
Sarcoma |
NCH |
QD |
Emory University |
Thyroid carcinoma |
NCH |
QF |
BLN - Baylor |
Uterine Corpus Endometrial Carcinoma |
NCH |
QG |
BLN - Baylor |
Colon adenocarcinoma |
NCH |
QH |
Fondazione-Besta |
Brain Lower Grade Glioma |
NCH |
QJ |
Mount Sinai School of Medicine |
Ovarian serous cystadenocarcinoma |
NCH |
QK |
Emory University - Winship Cancer Inst. |
Head and Neck squamous cell carcinoma |
NCH |
QL |
University of Chicago |
Colon adenocarcinoma |
NCH |
QM |
University of Oklahoma HSC |
Uterine Carcinosarcoma |
NCH |
QN |
ILSBio |
Uterine Carcinosarcoma |
NCH |
QQ |
Roswell Park |
Sarcoma |
NCH |
QR |
National Institutes of Health |
Pheochromocytoma and Paraganglioma |
NCH |
QS |
Candler |
Uterine Corpus Endometrial Carcinoma |
NCH |
QT |
University of North Carolina |
Pheochromocytoma and Paraganglioma |
NCH |
QU |
Harvard Beth Israel |
Prostate adenocarcinoma |
NCH |
QV |
Instituto Nacional de Cancerologia |
Cervical squamous cell carcinoma and endocervical adenocarcinoma |
NCH |
QW |
Instituto Nacional de Cancerologia |
Stomach adenocarcinoma |
NCH |
R1 |
CHI-Penrose Colorado |
Colon adenocarcinoma |
NCH |
R2 |
CHI-Penrose Colorado |
Cervical squamous cell carcinoma and endocervical adenocarcinoma |
NCH |
R3 |
CHI-Penrose Colorado |
Bladder Urothelial Carcinoma |
NCH |
R5 |
MD Anderson Cancer Center |
Stomach adenocarcinoma |
NCH |
R6 |
MD Anderson Cancer Center |
Esophageal carcinoma |
NCH |
R7 |
Gundersen Lutheran Health System |
Head and Neck squamous cell carcinoma |
NCH |
R8 |
MD Anderson |
Brain Lower Grade Glioma |
NCH |
R9 |
Candler |
Ovarian serous cystadenocarcinoma |
NCH |
RA |
Candler |
Cervical squamous cell carcinoma and endocervical adenocarcinoma |
NCH |
RB |
Emory University |
Pancreatic adenocarcinoma |
NCH |
RC |
University of Utah |
Liver hepatocellular carcinoma |
NCH |
RD |
Peter MacCallum Cancer Center |
Stomach adenocarcinoma |
NCH |
RE |
Peter MacCallum Cancer Center |
Esophageal carcinoma |
NCH |
RG |
Montefiore Medical Center |
Liver hepatocellular carcinoma |
NCH |
RH |
BLN - Baylor |
Head and Neck squamous cell carcinoma |
NCH |
RL |
St. Joseph's Hospital AZ |
Pancreatic adenocarcinoma |
NCH |
RM |
St. Joseph's Hospital AZ |
Pheochromocytoma and Paraganglioma |
NCH |
RN |
St. Joseph's Hospital AZ |
Sarcoma |
NCH |
RP |
St. Joseph's Hospital AZ |
Skin Cutaneous Melanoma |
NCH |
RQ |
St. Joseph's Hospital AZ |
Lymphoid Neoplasm Diffuse Large B-cell Lymphoma |
NCH |
RR |
St. Joseph's Hospital AZ |
Glioblastoma multiforme |
NCH |
RS |
Memorial Sloan Kettering Cancer Center |
Head and Neck squamous cell carcinoma |
NCH |
RT |
Cleveland Clinic Foundation |
Pheochromocytoma and Paraganglioma |
NCH |
RU |
Northwestern University |
Colon adenocarcinoma |
NCH |
RV |
Northwestern University |
Pancreatic adenocarcinoma |
NCH |
RW |
Michigan University |
Pheochromocytoma and Paraganglioma |
NCH |
RX |
University of Minnesota |
Pheochromocytoma and Paraganglioma |
NCH |
RY |
University of California San Francisco |
Brain Lower Grade Glioma |
NCH |
RZ |
Wills Eye Institute |
Uveal Melanoma |
NCH |
S2 |
Albert Einstein Medical Center |
Lung adenocarcinoma |
NCH |
S3 |
Albert Einstein Medical Center |
Breast invasive carcinoma |
NCH |
S4 |
University of Chicago |
Pancreatic adenocarcinoma |
NCH |
S5 |
University of Oklahoma HSC |
Bladder Urothelial Carcinoma |
NCH |
S6 |
Gundersen Lutheran Health System |
Testicular Germ Cell Tumors |
NCH |
S7 |
University Hospital Motol |
Pheochromocytoma and Paraganglioma |
NCH |
S8 |
ABS - IUPUI |
Esophageal carcinoma |
NCH |
S9 |
Dept of Neurosurgery at University of Heidelberg |
Brain Lower Grade Glioma |
NCH |
SA |
ABS - IUPUI |
Pheochromocytoma and Paraganglioma |
NCH |
SB |
Baylor College of Medicine |
Testicular Germ Cell Tumors |
NCH |
SC |
Memorial Sloan Kettering |
Mesothelioma |
NCH |
SD |
MD Anderson |
Pancreatic adenocarcinoma |
NCH |
SE |
Boston Medical Center |
Pheochromocytoma and Paraganglioma |
NCH |
SG |
Cleveland Clinic Foundation |
Sarcoma |
NCH |
SH |
Papworth Hospital |
Mesothelioma |
NCH |
SI |
Washington University St. Louis |
Sarcoma |
NCH |
SJ |
Albert Einstein Medical Center |
Uterine Corpus Endometrial Carcinoma |
NCH |
SK |
St. Joseph's Hospital AZ |
Colon adenocarcinoma |
NCH |
SL |
St. Joseph's Hospital AZ |
Uterine Corpus Endometrial Carcinoma |
NCH |
SN |
BLN - Baylor |
Testicular Germ Cell Tumors |
NCH |
SO |
University of Minnesota |
Testicular Germ Cell Tumors |
NCH |
SP |
University Health Network |
Pheochromocytoma and Paraganglioma |
NCH |
SQ |
International Genomics Consortium |
Pheochromocytoma and Paraganglioma |
NCH |
SR |
Tufts Medical Center |
Pheochromocytoma and Paraganglioma |
NCH |
SS |
Medical College of Georgia |
Colon adenocarcinoma |
NCH |
ST |
Global Bioclinical-Moldova |
Head and Neck squamous cell carcinoma |
NCH |
SU |
Global Bioclinical-Moldova |
Prostate adenocarcinoma |
NCH |
SW |
Global Bioclinical-Moldova |
Stomach adenocarcinoma |
NCH |
SX |
Mayo Clinic Arizona |
Kidney renal papillary cell carcinoma |
NCH |
SY |
Mayo Clinic Arizona |
Bladder Urothelial Carcinoma |
NCH |
T1 |
St. Joseph's Hospital Arizona |
Liver hepatocellular carcinoma |
NCH |
T2 |
St. University of Colorado Denver |
Head and Neck squamous cell carcinoma |
NCH |
T3 |
Molecular Response |
Head and Neck squamous cell carcinoma |
NCH |
T6 |
Molecular Response |
Lung adenocarcinoma |
NCH |
T7 |
Molecular Response |
Kidney renal clear cell carcinoma |
NCH |
T9 |
Molecular Response |
Colon adenocarcinoma |
NCH |
TE |
Global BioClinical - Georgia |
Skin Cutaneous Melanoma |
NCH |
TG |
Global BioClinical - Georgia |
Head and Neck squamous cell carcinoma |
NCH |
TK |
Global BioClinical - Georgia |
Prostate adenocarcinoma |
NCH |
TL |
Global BioClinical - Georgia |
Stomach adenocarcinoma |
NCH |
TM |
The University of New South Wales |
Brain Lower Grade Glioma |
NCH |
TN |
Ohio State University |
Head and Neck squamous cell carcinoma |
NCH |
TP |
Maine Medical Center |
Prostate adenocarcinoma |
NCH |
TQ |
University of Sao Paulo |
Brain Lower Grade Glioma |
NCH |
TR |
Global Bioclinical-Moldova |
Skin Cutaneous Melanoma |
NCH |
TS |
University of Pennsylvania |
Mesothelioma |
NCH |
TT |
University of Pennsylvania |
Pheochromocytoma and Paraganglioma |
NCH |
TV |
Wake Forest University |
Breast invasive carcinoma |
NCH |
UB |
UCSF |
Liver hepatocellular carcinoma |
NCH |
UC |
University of Washington |
Cervical squamous cell carcinoma and endocervical adenocarcinoma |
NCH |
UD |
University of Western Australia |
Mesothelioma |
NCH |
UE |
Asterand |
Sarcoma |
NCH |
UF |
Barretos Cancer Hospital |
Head and Neck squamous cell carcinoma |
NCH |
UJ |
Boston Medical Center |
Lung squamous cell carcinoma |
NCH |
UL |
Boston Medical Center |
Breast invasive carcinoma |
NCH |
UN |
Boston Medical Center |
Kidney renal papillary cell carcinoma |
NCH |
UP |
Boston Medical Center |
Head and Neck squamous cell carcinoma |
NCH |
UR |
Boston Medical Center |
Prostate adenocarcinoma |
NCH |
US |
Garvan Institute of Medical Research |
Pancreatic adenocarcinoma |
NCH |
UT |
Asbestos Diseases Research Institute |
Mesothelioma |
NCH |
UU |
Mary Bird Perkins Cancer Center - Our Lady of the Lake |
Breast invasive carcinoma |
NCH |
UV |
Capital Biosciences |
Liver hepatocellular carcinoma |
NCH |
UW |
University of North Carolina |
Kidney Chromophobe |
NCH |
UY |
University of California San Francisco |
Bladder Urothelial Carcinoma |
NCH |
UZ |
University of California San Francisco |
Kidney renal papillary cell carcinoma |
NCH |
V1 |
University of California San Francisco |
Prostate adenocarcinoma |
NCH |
V2 |
Cleveland Clinic Foundation |
Prostate adenocarcinoma |
NCH |
V3 |
Cleveland Clinic Foundation |
Uveal Melanoma |
NCH |
V4 |
Institut Curie |
Uveal Melanoma |
NCH |
V5 |
Duke University |
Esophageal carcinoma |
NCH |
V6 |
Duke University |
Stomach adenocarcinoma |
NCH |
V7 |
Medical College of Georgia |
Breast invasive carcinoma |
NCH |
V8 |
Medical College of Georgia |
Kidney renal clear cell carcinoma |
NCH |
V9 |
Medical College of Georgia |
Kidney renal papillary cell carcinoma |
NCH |
VA |
Alliance |
Stomach adenocarcinoma |
NCH |
VB |
Global BioClinical - Georgia |
Lymphoid Neoplasm Diffuse Large B-cell Lymphoma |
NCH |
VD |
University of Liverpool |
Uveal Melanoma |
NCH |
VF |
University of Pennsylvania |
Testicular Germ Cell Tumors |
NCH |
VG |
Institute of Human Virology Nigeria |
Ovarian serous cystadenocarcinoma |
NCH |
VK |
Institute of Human Virology Nigeria |
Colon adenocarcinoma |
NCH |
VL |
Institute of Human Virology Nigeria |
Rectum adenocarcinoma |
NCH |
VM |
Huntsman Cancer Institute |
Brain Lower Grade Glioma |
NCH |
VN |
NCI Urologic Oncology Branch |
Prostate adenocarcinoma |
NCH |
VP |
Washington University |
Prostate adenocarcinoma |
NCH |
VQ |
Barretos Cancer Hospital |
Stomach adenocarcinoma |
NCH |
VR |
Barretos Cancer Hospital |
Esophageal carcinoma |
NCH |
VS |
Barretos Cancer Hospital |
Cervical squamous cell carcinoma and endocervical adenocarcinoma |
NCH |
VT |
Vanderbilt |
Sarcoma |
NCH |
VV |
John Wayne Cancer Center |
Brain Lower Grade Glioma |
NCH |
VW |
Northwestern University |
Brain Lower Grade Glioma |
NCH |
VX |
Northwestern University |
Stomach adenocarcinoma |
NCH |
VZ |
Albert Einstein Medical Center |
Pheochromocytoma and Paraganglioma |
NCH |
W2 |
Medical College of Wisconsin |
Pheochromocytoma and Paraganglioma |
NCH |
W3 |
John Wayne Cancer Center |
Skin Cutaneous Melanoma |
NCH |
W4 |
University of North Carolina |
Testicular Germ Cell Tumors |
NCH |
W5 |
Mayo Clinic Rochester |
Cholangiocarcinoma |
NCH |
W6 |
UCSF |
Cholangiocarcinoma |
NCH |
W7 |
Garvan Institute of Medical Research |
Cholangiocarcinoma |
NCH |
W8 |
Greenville Health System |
Breast invasive carcinoma |
NCH |
W9 |
University of Kansas |
Brain Lower Grade Glioma |
NCH |
WA |
University of Schleswig-Holstein |
Head and Neck squamous cell carcinoma |
NCH |
WB |
Erasmus MC |
Pheochromocytoma and Paraganglioma |
NCH |
WC |
MD Anderson |
Uveal Melanoma |
NCH |
WD |
Emory University |
Cholangiocarcinoma |
NCH |
WE |
Norfolk and Norwich Hospital |
Skin Cutaneous Melanoma |
NCH |
WF |
Greenville Health System |
Pancreatic adenocarcinoma |
NCH |
WG |
Greenville Health System |
Lung squamous cell carcinoma |
NCH |
WH |
Greenville Health System |
Brain Lower Grade Glioma |
NCH |
WJ |
Greenville Health System |
Liver hepatocellular carcinoma |
NCH |
WK |
Brigham and Women's Hospital |
Sarcoma |
NCH |
WL |
University of Kansas |
Cervical squamous cell carcinoma and endocervical adenocarcinoma |
NCH |
WM |
University of Kansas |
Kidney renal clear cell carcinoma |
NCH |
WN |
University of Kansas |
Kidney renal papillary cell carcinoma |
NCH |
WP |
University of Kansas |
Sarcoma |
NCH |
WQ |
University of Kansas |
Liver hepatocellular carcinoma |
NCH |
WR |
University of Kansas |
Ovarian serous cystadenocarcinoma |
NCH |
WS |
University of Kansas |
Colon adenocarcinoma |
NCH |
WT |
University of Kansas |
Breast invasive carcinoma |
NCH |
WU |
Wake Forest University |
Colon adenocarcinoma |
NCH |
WW |
Wake Forest University |
Prostate adenocarcinoma |
NCH |
WX |
Yale University |
Liver hepatocellular carcinoma |
NCH |
WY |
Johns Hopkins |
Brain Lower Grade Glioma |
NCH |
WZ |
International Genomics Consortium |
Testicular Germ Cell Tumors |
NCH |
X2 |
University of Washington |
Sarcoma |
NCH |
X3 |
Cleveland Clinic Foundation |
Testicular Germ Cell Tumors |
NCH |
X4 |
Institute for Medical Research |
Prostate adenocarcinoma |
NCH |
X5 |
Institute of Human Virology Nigeria |
Bladder Urothelial Carcinoma |
NCH |
X6 |
University of Iowa |
Sarcoma |
NCH |
X7 |
ABS IUPUI |
Thymoma |
NCH |
X8 |
St. Joseph's Hospital Arizona |
Esophageal carcinoma |
NCH |
X9 |
University of California, Davis |
Sarcoma |
NCH |
XA |
University of Minnesota |
Prostate adenocarcinoma |
NCH |
XB |
Albert Einstein Medical Center |
Esophageal carcinoma |
NCH |
XC |
Albert Einstein Medical Center |
Lung squamous cell carcinoma |
NCH |
XD |
Providence Portland Medical Center |
Pancreatic adenocarcinoma |
NCH |
XE |
University of Southern California |
Testicular Germ Cell Tumors |
NCH |
XF |
University of Southern California |
Bladder Urothelial Carcinoma |
NCH |
XG |
BLN UT Southwestern Medical Center at Dallas |
Pheochromocytoma and Paraganglioma |
NCH |
XH |
BLN Baylor |
Thymoma |
NCH |
XJ |
University of Kansas |
Prostate adenocarcinoma |
NCH |
XK |
Mayo Clinic Arizona |
Prostate adenocarcinoma |
NCH |
XM |
MSKCC |
Thymoma |
NCH |
XN |
University of Sao Paulo |
Pancreatic adenocarcinoma |
NCH |
XP |
University of Sao Paulo |
Esophageal carcinoma |
NCH |
XQ |
University of Sao Paulo |
Prostate adenocarcinoma |
NCH |
XR |
University of Sao Paulo |
Liver hepatocellular carcinoma |
NCH |
XS |
University of Sao Paulo |
Cervical squamous cell carcinoma and endocervical adenocarcinoma |
NCH |
XT |
Johns Hopkins |
Mesothelioma |
NCH |
XU |
University Health Network |
Thymoma |
NCH |
XV |
Capital Biosciences |
Skin Cutaneous Melanoma |
NCH |
XX |
Spectrum Health |
Breast invasive carcinoma |
NCH |
XY |
Spectrum Health |
Testicular Germ Cell Tumors |
NCH |
Y3 |
University of New Mexico |
Acute Myeloid Leukemia |
NCH |
Y5 |
University of Arizona |
Sarcoma |
NCH |
Y6 |
University of Arizona |
Prostate adenocarcinoma |
NCH |
Y8 |
Spectrum Health |
Kidney renal papillary cell carcinoma |
NCH |
YA |
Spectrum Health |
Liver hepatocellular carcinoma |
NCH |
YB |
Spectrum Health |
Pancreatic adenocarcinoma |
NCH |
YC |
Spectrum Health |
Bladder Urothelial Carcinoma |
NCH |
YD |
Spectrum Health |
Skin Cutaneous Melanoma |
NCH |
YF |
University of Puerto Rico |
Bladder Urothelial Carcinoma |
NCH |
YG |
University of Puerto Rico |
Skin Cutaneous Melanoma |
NCH |
YH |
Stanford University |
Pancreatic adenocarcinoma |
NCH |
YJ |
Stanford University |
Prostate adenocarcinoma |
NCH |
YL |
PROCURE Biobank |
Prostate adenocarcinoma |
NCH |
YN |
University of Arizona |
Skin Cutaneous Melanoma |
NCH |
YR |
Barretos Cancer Hospital |
Cholangiocarcinoma |
NCH |
YS |
Barretos Cancer Hospital |
Mesothelioma |
NCH |
YT |
Barretos Cancer Hospital |
Thymoma |
NCH |
YU |
Barretos Cancer Hospital |
Testicular Germ Cell Tumors |
NCH |
YV |
MSKCC |
Uveal Melanoma |
NCH |
YW |
Albert Einstein Medical Center |
Sarcoma |
NCH |
YX |
Emory University |
Stomach adenocarcinoma |
NCH |
YY |
Roswell Park |
Pancreatic adenocarcinoma |
NCH |
YZ |
The Ohio State University |
Uveal Melanoma |
NCH |
Z2 |
IDI-IRCCS |
Skin Cutaneous Melanoma |
NCH |
Z3 |
UCLA |
Sarcoma |
NCH |
Z4 |
Cureline |
Sarcoma |
NCH |
Z5 |
Cureline |
Pancreatic adenocarcinoma |
NCH |
Z6 |
Cureline |
Esophageal carcinoma |
NCH |
Z7 |
John Wayne Cancer Center |
Breast invasive carcinoma |
NCH |
Z8 |
John Wayne Cancer Center |
Pancreatic adenocarcinoma |
NCH |
ZA |
Candler |
Stomach adenocarcinoma |
NCH |
ZB |
Thoraxklinik |
Thymoma |
NCH |
ZC |
University of Mannheim |
Thymoma |
NCH |
ZD |
ILSbio |
Cholangiocarcinoma |
NCH |
ZE |
Spectrum Health |
Lung squamous cell carcinoma |
NCH |
ZF |
University of Sheffield |
Bladder Urothelial Carcinoma |
NCH |
ZG |
University Medical Center Hamburg-Eppendorf |
Prostate adenocarcinoma |
NCH |
ZH |
University of North Carolina |
Cholangiocarcinoma |
NCH |
ZJ |
NCI HRE Branch |
Cervical squamous cell carcinoma and endocervical adenocarcinoma |
NCH |
ZK |
University of New Mexico |
Cholangiocarcinoma |
NCH |
ZL |
Valley Hospital |
Thymoma |
NCH |
ZM |
University of Ulm |
Testicular Germ Cell Tumors |
NCH |
ZN |
Brigham and Women's Hospital Division of Thoracic Surgery |
Mesothelioma |
NCH |
ZP |
Medical College of Wisconsin |
Liver hepatocellular carcinoma |
NCH |
ZQ |
Tayside Tissue Bank |
Stomach adenocarcinoma |
NCH |
ZR |
Tayside Tissue Bank |
Esophageal carcinoma |
NCH |
ZS |
Tayside Tissue Bank |
Liver hepatocellular carcinoma |
NCH |
ZT |
International Genomics Consortium |
Thymoma |
NCH |
ZU |
Spectrum Health |
Cholangiocarcinoma |
NCH |
ZW |
University of Alabama |
Pancreatic adenocarcinoma |
NCH |
ZX |
University of Alabama |
Cervical squamous cell carcinoma and endocervical adenocarcinoma |
NCH |